The phenotype of gut endocrine tumours.
Endocrine tumours of gut and pancreas tract are rare entities originating from cells of the diffuse endocrine system. The endocrine phenotype is assessed by the expression of general and specific endocrine markers. General endocrine markers associate to organelles like large dense core vesicles (e.g. chromogranin A) and small synaptic-like vesicles (e.g. synaptophysin), or to the cytosol, like neuron specific enolase and protein gene product 9.5 (PGP9.5). The specific markers correspond to the hormones produced by tumour cells. Two major categories of endocrine tumours are identified as (i) well-differentiated and (ii) poorly differentiated neoplasms. Well-differentiated tumours/carcinomas (also known as carcinoids) express all general markers of endocrine differentiation and various hormones. Poorly differentiated endocrine carcinomas lack large dense core vesicles markers (chromogranin A), while widely express synaptophysin and cytosol endocrine markers. The clinical behaviour of endocrine tumours spans from benign to low-grade malignant for well-differentiated tumours/carcinomas to high grade malignant for poorly differentiated carcinomas. The Multiple Endocrine Neoplasia type 1 syndrome (MEN1) gene is involved in the genesis of a proportion of both well- and poorly differentiated sporadic tumours. p53 gene abnormality appears as restricted to poorly differentiated endocrine carcinomas.
Rindi
G
G
Department of Pathology and Laboratory Medicine, University of Parma, Via Gramsci 14, I-43100 Parma, Italy. guido.rindi@unipr.it
Ubiali
A
A
Villanacci
V
V
D014408:Biomarkers, Tumor / Q000032:analysis; D004701:Endocrine Gland Neoplasms / Q000145:classification / Q000235:genetics; D005770:Gastrointestinal Neoplasms / Q000145:classification / Q000235:genetics; D006801:Humans; D010641:Phenotype
D014408:Biomarkers, Tumor